Skip to main content
FDA approves two JAK-1 inhibitors for moderate to severe atopic dermatitis
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA approves two JAK-1 inhibitors for moderate to severe atopic dermatitis
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
0.98
Food and Drug Administration (FDA)
0
0.72
Atopic Dermatitis
0
1
Clinical Research
0
0.24
Cyclosporine
0
0.24
Health Insurance
0
0.17
Revenue and Practice Management
0
0.17
Topical Corticosteroid
0
0.17
Calcaneal
0
0.12
Child
0
0.12
Corticosteroids
0
0.12
Eczema
0
0.12
Insurance
0
0.12
New York
0
0.12
Severity Index
0
0.12
Thrombosis
0
0.12
Biologic Therapy
0
0.11
Thromboembolism
0
0.11
Specialty
Lead
score
Dermatology
1
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
1
Pharmacist
0
0.82
Allergy & Clinical Immunology
0
0.72
Pediatrics
0
0.57
Business of Medicine
0
0.18